News

Bio-Rad Launches NGC Fraction Collector for NGC Chromatography Systems

Bio-Rad Laboratories, Inc. has launched the new NGC Fraction Collector. When used with the NGC Chromatography System, the NGC Fraction Collector provides the flexibility and collection capacity needed for any application, from discovery to scale-up. The NGC Fraction Collector allows researchers to choose how to collect and when to access their fractions. The system can be triggered to collect based on slope, percent of buffer from pump B, pH, and detector signals. Front-to-back dispensing provides easy access to fractions before…

AGC Bioscience, Biomeva, and CMC Biologics to Provide Services Under the Brand AGC Biologics

AGC Biologics, a convergence of Asahi Glass Company (AGC) Bioscience, Biomeva GmbH, and CMC Biologics, announced today that effective January 8, 2018, the company will be integrated and newly branded as AGC Biologics. AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, will offer the highest level of CDMO services to its clients from their state-of-the-art facilities in Seattle, WA and Berkeley, CA in the US; Copenhagen, Denmark; Heidelberg, Germany; Chiba, Japan; and Yokohama, Japan. The…

Abzena Selects Sartorius Stedim Biotech to Equip Development and Manufacturing Sites in the United States

Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S. Abzena has selected Sartorius Stedim to equip its integrated CDMO facilities in Bristol, PA (development and GMP manufacture of antibody drug conjugates) and San Diego, CA (development and GMP manufacture of monoclonal antibodies and other recombinant proteins). Sartorius Stedim will provide both facilities with end-to-end process solutions in…

Sekisui XenoTech Global Contract Research Organization is Hiring and Growing to Meet Customer Demand

Sekisui XenoTech is a global contract research organization based in Kansas City, KS. The company hired a record number of new staff over the past year in order to meet current demand for its products and services, which are utilized to optimize the discovery, development, and approval of new drugs and other compounds. Several previous Sekisui XenoTech employees also returned to the company. The new staff span Sekisui XenoTech’s contract research, quality assurance, business, IT, and other departments. “Our hiring…

JSR Announces Acquisition of Crown Biosciences International

JSR Life Sciences (JLS) announced today that JSR Corporation has agreed to purchase Crown Bioscience International (TPEx: ticker 6554) at 12 Billion New Taiwan Dollar, a global drug discovery and development services company providing translational platforms to advanced oncology, inflammation, cardiovascular and metabolic disease research. This acquisition marks JSR’s largest life sciences-focused investment to date, extending the company’s portfolio to include industry-leading contract research and development capabilities, and ability to develop impactful solutions for pharma. As a premier contract research…

AdvantaPure® Introduces Single-Use Filling Assemblies For Aseptic Fill & Finish Applications

New sterile molded filling assemblies from AdvantaPure continue the shift to single-use processing methods that save time, reduce cross contamination risks and increase productivity between batches of biopharmaceutical and pharmaceutical products. “These assemblies were developed specifically for vial and syringe filling,” notes Lawrence Morano, AdvantaPure’s global sales manager. “Our team of engineers is well versed in single-use, biopharmaceutical manufacturing, and fluid flow, and we’re able to work closely with customers to design systems that meet their individual process requirements.” Manufactured…

GEA Optimizes Monitoring of Powder Flow, Fluidization and Cleaning

GEA Service recently launched its new VISIOCOVER™ Upgrade Program for the safe visual inspection of non-sticky-powder processes in the dairy, food, chemical and pharma industries. For customers currently using SANICOVER™ to monitor their powder flow, fluidization and cleaning, the upgrade provides three standard sizes to match the SANICOVER™ systems. Installing the VISIOCOVER™ on existing SANICOVER™ installations is easy and allows the technician to safely inspect the production without opening the cover, which would risk contaminating the product. The VISIOCOVER™ Cam…

Sartorius Stedim Biotech Launches SIMCA and SIMCA-online Software Updates

Sartorius Stedim Biotech (SSB) has introduced a new version of its SIMCA® and SIMCA®-online data analytical solutions, which are offered by its subsidiary Sartorius Stedim Data Analytics, formerly known as Umetrics. Every day, businesses generate a vast array of data derived from a variety of different sources. This data holds the key to better performance. The challenge is to interpret this information in a meaningful way. However, with so many parameters and such vast system complexity to consider, it is…

Second Sartorius Research Xchange Forum Focuses on Regenerative Medicine and Cell Therapy

Promoting interdisciplinary exchange between science and industry on the topics of regenerative medicine and cell therapy: this is the objective Sartorius will be pursuing by hosting its second Research Xchange Forum on March 20 and 21, 2018, at Sartorius College in Goettingen. Experts from the biotechnology sector will report on the new developments in cell therapy. Sartorius has gained guest speakers Dr. Priscilla N. Kelly, editor of the journal Science, and Dr. Stefan W. Hell, the winner of the Nobel…

Dynamk Capital Invests in Envisagenics to Advance AI Drug Discovery

Dynamk Capital, a recently launched life sciences venture capital fund, today announced an exciting new investment in early drug discovery by adding Envisagenics, Inc. to its growing portfolio. Dynamk’s portfolio companies provide technologies and services that enable biopharmaceutical companies around the world to develop therapeutics faster and produce them more economically. Dynamk Capital invested $500,000 in Envisagenics, leading the $2.25 million seed round alongside other investors. Envisagenics, a life science company applies artificial intelligence to the genetic sequence of patients…